Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Immune Globulin Subcutaenous (Human), 20%

NCT01412385

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Medizinische Universität Wien / AHK Wien (General Hospital Vienna), Universitätsklinik für Kinder- und Jugendheilkunde Vienna, Austria
  • Universitätsklinikum Erlangen, Medizinische Klinik 3 Erlangen, Germany
  • University Medical Centre Freiburg, Centre of Chronic Immunodeficiency, Divison of Rheumatology and Clinical Immunology Freiburg im Breisgau, Germany
  • Universitätsklinikum Hamburg-Eppendorf, Kinderklinik Hamburg, Germany
View Trial Details
Completed

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

NCT00782106

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • First Allergy and Clinical Research Center Centennial, Colorado, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Pediatrics Allergy/Immunology Association, PA Dallas, Texas, United States
View Trial Details
Completed

International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife)

NCT03468673

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
Locations
  • University of Sydney Sydney, Australia
  • Center of treatment HIV/Aids - Brazil São Paulo, Brazil
  • Clinique m&dicale L'Actuel Montreal, Quebec, Canada
  • CHU de Bordeaux Bordeaux, France
View all 17 locations
View Trial Details
Completed

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

NCT01815736

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Southwest Center for HIV/AIDS Phoenix, Arizona, United States
  • Spectrum Medical Group Phoenix, Arizona, United States
  • Health for Life Clinic PLLC Little Rock, Arkansas, United States
View all 167 locations
View Trial Details

Related conditions